Efficacy and safety of darbepoetin alfa administered every 3 weeks in children with solid tumours receiving chemotherapy

Vasiliki Fragandrea-Sidi, Chaido Tsantali, Ioanna Fragandrea, Emmanouil Hatzipantelis, Dimitrios Koliouskas

Research output: Contribution to conferencePosterpeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of darbepoetin alfa administered every 3 weeks in children with solid tumours receiving chemotherapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science